title: Roles of purine nucleotides and adenosine in enhancing NOS II gene expression in interleukin-1 beta-stimulated rat vascular smooth muscle cells.
abstract: The production of nitric oxide (NO) by vascular smooth muscle cells (VSMC) is stimulated by interleukin-1 beta (IL-1 beta). This is enhanced in a dose-dependent manner by ADP, although it alone failed to induce nitrite accumulation. Purine nucleotides and their nonhydrolizable analogues as well as adenosine also exhibit variable enhancing effects. This enhanced nitrite formation was due to induction of the NO synthase (NOS II) gene as judged by Northern hybridization using an NOS II specific probe and by Ca2+ independency of the NOS II activity. 8-(p-Sulfophenyl)-theophylline, a blocker of adenosine receptors, suppressed the enhanced NO production by adenosine and ADP to the level of that with IL-1 beta alone. These data indicate that activation of the adenosine receptor on VSMC may enhance production of NOS II by modulating a signal transducing pathway of IL-1 beta. Although cAMP is a candidate as the second messenger, it was not significantly elevated by either ADP or adenosine treatment in IL-1 beta-stimulated cells. This mechanism might be stimulated under conditions with release of various purine and their derivatives.
authors.affiliation: Department of Biochemistry, Osaka University Medical School, Japan.
authors.forename: H G
authors.initials: HG
authors.lastname: Seo
authors.forename: J
authors.initials: J
authors.lastname: Fujii
authors.forename: M
authors.initials: M
authors.lastname: Asahi
authors.forename: A
authors.initials: A
authors.lastname: Okado
authors.forename: N
authors.initials: N
authors.lastname: Fujiwara
authors.forename: N
authors.initials: N
authors.lastname: Taniguchi
mesh_terms: D000241:Adenosine / Q000378:metabolism / Q000502:physiology*; D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D005786:Gene Expression Regulation / Q000187:drug effects*; D007375:Interleukin-1 / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D019001:Nitric Oxide Synthase / Q000235:genetics* / Q000378:metabolism; D009573:Nitrites / Q000737:chemistry; D011685:Purine Nucleotides / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D018047:Receptors, Purinergic P1 / Q000235:genetics / Q000502:physiology; D014158:Transcription, Genetic
chemical_list: D007375:Interleukin-1; D009573:Nitrites; D011685:Purine Nucleotides; D018047:Receptors, Purinergic P1; D000244:Adenosine Diphosphate; D019001:Nitric Oxide Synthase; D000241:Adenosine